Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
60 participants
INTERVENTIONAL
2023-04-10
2027-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accelerated rTMS for Post-Stroke Apathy
NCT05878457
fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI
NCT02980484
Effect of Repetitive Transcranial Magnetic Stimulation on Neurological Recovery in Patients With Ischaemic Stroke
NCT06415734
Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation(rTMS) on the Recovery After Stroke
NCT01311271
rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke
NCT03441334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real M1 High Frequency rTMS
Participants will be randomly assigned to receive high-frequency repetitive transcranial magnetic stimulation (rTMS) to the top of their head for approximately 40 minutes.
High frequency repetitive transcranial magnetic stimulation
MAGSTIM Super Rapid2 Plus
Real LDLPFC High Frequency rTMS
Participants will be randomly assigned to receive high-frequency repetitive transcranial magnetic stimulation (rTMS) to the left frontal part of their head for approximately 40 minutes.
High frequency repetitive transcranial magnetic stimulation
MAGSTIM Super Rapid2 Plus
Sham rTMS
Participants will be randomly assigned to receive sham/placebo repetitive transcranial magnetic stimulation (rTMS) to the their head for approximately 40 minutes. This is a control condition.
Sham repetitive transcranial magnetic stimulation
MAGSTIM Super Rapid2 Plus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High frequency repetitive transcranial magnetic stimulation
MAGSTIM Super Rapid2 Plus
Sham repetitive transcranial magnetic stimulation
MAGSTIM Super Rapid2 Plus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* more than 6 months post-stroke
* able to walk 10m unassisted
* Clinically present fatigue
Exclusion Criteria
* Inability to follow simple three-step instructions
* Multiple strokes on opposite hemispheres
* Cerebellar and/or brainstem strokes
* Diagnosed comorbid neurological conditions (e.g. multiple sclerosis, Parkinson's disease, moderate/severe TBI)
* Comorbid psychological conditions (e.g. depression, anxiety, PTSD)
* strokes within stimulation sites
* Pregnancy
* Severe hypertension (resting SBP \> 200, DBP \> 120)
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ralph H. Johnson VA Medical Center
FED
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John H Kindred
Role: PRINCIPAL_INVESTIGATOR
Ralph H. Johnson VA Medical Center, Charleston, SC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00120805
Identifier Type: OTHER
Identifier Source: secondary_id
N3790-W
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.